PharmaVoice Jan 20, 2026 Texas, N. Carolina, Ohio, Pennsylvania — where pharma manufacturing investments have surged
Agilent Jan 20, 2026 HSBC Initiates Coverage of Agilent Technologies (A) with Buy Recommendation - Nasdaq
FierceBiotech Jan 20, 2026 GSK pays $2.2B to buy Rapt for its phase 2-stage food allergy challenger to Xolair
FierceBiotech Jan 20, 2026 ARPA-H director eyes future beyond vaccines, ‘winning the biotech race’ against China
BioPharma Dive Jan 20, 2026 Kailera’s Ron Renaud on how a China-linked startup can compete in obesity
Agilent Jan 20, 2026 Agilent Technologies (A) Initiated with "Buy" Rating by HSBC | A Stock News - GuruFocus
Agilent Jan 20, 2026 Agilent Technologies (A) Initiated with "Buy" Rating by HSBC | A Stock News - GuruFocus
Illumina Jan 20, 2026 Illumina Inc. (ILMN) Shares See Target Boost as Analysts See Potential 2026 Upside - Insider Monkey